Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

IMPORTANCE: Immune checkpoint blockade (ICB) has improved the survival of patients with advanced melanoma. Durable responses are observed for 40% to 60% of patients, depending on treatment regimens. However, there is still large variability in the response to treatment with ICB, and patients experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolte, Laura A., Lee, Karla A., Björk, Johannes R., Leeming, Emily R., Campmans-Kuijpers, Marjo J. E., de Haan, Jacco J., Vila, Arnau Vich, Maltez-Thomas, Andrew, Segata, Nicola, Board, Ruth, Harries, Mark, Lorigan, Paul, de Vries, Elisabeth G. E., Nathan, Paul, Fehrmann, Rudolf, Bataille, Véronique, Spector, Tim D., Hospers, Geke A. P., Weersma, Rinse K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936383/
https://www.ncbi.nlm.nih.gov/pubmed/36795408
http://dx.doi.org/10.1001/jamaoncol.2022.7753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936383/
https://www.ncbi.nlm.nih.gov/pubmed/36795408
http://dx.doi.org/10.1001/jamaoncol.2022.7753

Ejemplares similares